| Product Code: ETC13134155 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Peripheral Circulatory Disease Treatment Market was valued at USD 1.2 Billion in 2024 and is expected to reach USD 1.8 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The Global Peripheral Circulatory Disease Treatment Market is experiencing significant growth due to the rising prevalence of peripheral artery disease (PAD) and other circulatory disorders worldwide. Key factors driving market growth include the increasing aging population, lifestyle changes leading to unhealthy habits, and the high prevalence of diabetes and obesity. The market is characterized by a range of treatment options such as medications, minimally invasive procedures, and surgical interventions to manage peripheral circulatory diseases. North America and Europe dominate the market due to advanced healthcare infrastructure and high awareness levels among the population. However, the Asia-Pacific region is expected to witness rapid growth in the coming years due to improving healthcare facilities and the rising incidence of circulatory diseases. Key players in the market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, and Cook Medical.
The Global Peripheral Circulatory Disease Treatment Market is experiencing growth due to the increasing prevalence of peripheral arterial disease (PAD) and the rising elderly population. Key trends include a shift towards minimally invasive procedures such as endovascular interventions, advancements in drug-eluting technologies for stents and balloons, and the development of novel therapies such as gene therapy and stem cell therapy. Opportunities in the market lie in emerging markets with unmet medical needs, strategic collaborations between healthcare providers and technology companies to enhance treatment outcomes, and the focus on personalized medicine for targeted interventions. Overall, the market is poised for expansion driven by technological innovations and the growing demand for effective treatment options for peripheral circulatory diseases.
The Global Peripheral Circulatory Disease Treatment Market faces several challenges, including limited awareness about the disease among individuals, leading to underdiagnosis and undertreatment. Another challenge is the high cost associated with advanced treatment options and procedures, which may hinder access to care for some patients. Additionally, the lack of standardized treatment guidelines and variability in healthcare infrastructure across different regions pose challenges in delivering optimal care to patients with peripheral circulatory diseases. Moreover, the increasing prevalence of risk factors such as diabetes, obesity, and sedentary lifestyles further complicates the management and treatment of peripheral circulatory diseases, necessitating a holistic approach involving lifestyle modifications, medication management, and invasive interventions. Addressing these challenges will be crucial in improving outcomes and reducing the burden of peripheral circulatory diseases globally.
The Global Peripheral Circulatory Disease Treatment Market is primarily driven by the increasing prevalence of peripheral artery disease (PAD) due to the rising geriatric population and lifestyle factors such as smoking and unhealthy diet. Advances in medical technology and the development of innovative treatment options, such as minimally invasive procedures and drug-eluting stents, are also fueling market growth. Additionally, the growing awareness about the importance of early diagnosis and treatment of peripheral circulatory diseases among both patients and healthcare providers is driving the demand for effective treatment solutions. Furthermore, government initiatives and healthcare reforms aimed at improving access to healthcare services for patients with peripheral circulatory diseases are expected to contribute to the market expansion.
Government policies related to the Global Peripheral Circulatory Disease Treatment Market aim to improve access to affordable treatment options, promote research and development of innovative therapies, and enhance healthcare infrastructure. These policies often focus on increasing awareness about peripheral circulatory diseases, implementing screening programs, and supporting preventive measures. Additionally, governments may offer incentives for companies to invest in developing new treatment technologies and drugs, as well as regulate the pricing and reimbursement of peripheral circulatory disease treatments to ensure affordability and accessibility for patients. Overall, government policies play a crucial role in shaping the landscape of the Global Peripheral Circulatory Disease Treatment Market by fostering a conducive environment for advancements in healthcare and addressing the growing burden of peripheral circulatory diseases worldwide.
The Global Peripheral Circulatory Disease Treatment Market is expected to witness steady growth in the coming years, driven by factors such as the rising prevalence of peripheral arterial diseases, increasing geriatric population, and advancements in minimally invasive treatment options. The market is likely to benefit from the growing awareness about the importance of early diagnosis and treatment of peripheral circulatory diseases. Technological innovations, such as drug-eluting stents and bioresorbable scaffolds, are anticipated to further propel market growth. Additionally, the increasing adoption of endovascular procedures and the development of novel therapies are expected to create lucrative opportunities for market players. However, challenges such as high treatment costs and limited access to advanced healthcare facilities in developing regions may hinder market growth to some extent.
In the Global Peripheral Circulatory Disease Treatment Market, North America holds a significant share due to a higher prevalence of peripheral artery disease (PAD) and advanced healthcare infrastructure. The region is characterized by a high adoption rate of advanced treatment modalities such as minimally invasive procedures and angioplasty. In Europe, the market is driven by the presence of key market players, increasing geriatric population, and rising awareness about peripheral circulatory diseases. Asia Pacific is projected to witness substantial growth attributed to the improving healthcare infrastructure, increasing disposable income, and a growing emphasis on early disease diagnosis. The Middle East and Africa region is expected to show steady growth due to improving healthcare facilities and rising investments in healthcare infrastructure. Latin America is also anticipated to exhibit growth driven by increasing healthcare expenditure and rising awareness about peripheral circulatory diseases.
Global Peripheral Circulatory Disease Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Peripheral Circulatory Disease Treatment Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Peripheral Circulatory Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Global Peripheral Circulatory Disease Treatment Market - Industry Life Cycle |
3.4 Global Peripheral Circulatory Disease Treatment Market - Porter's Five Forces |
3.5 Global Peripheral Circulatory Disease Treatment Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Peripheral Circulatory Disease Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Peripheral Circulatory Disease Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Global Peripheral Circulatory Disease Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Peripheral Circulatory Disease Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Global Peripheral Circulatory Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Peripheral Circulatory Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Peripheral Circulatory Disease Treatment Market Trends |
6 Global Peripheral Circulatory Disease Treatment Market, 2021 - 2031 |
6.1 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Peripheral Vascular Diseases, 2021 - 2031 |
6.1.3 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Peripheral Artery Diseases, 2021 - 2031 |
6.2 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Cholesterol Lowering Medications, 2021 - 2031 |
6.2.3 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By High Blood Pressure Medication, 2021 - 2031 |
6.2.4 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Medication to Prevent Blood Clots, 2021 - 2031 |
6.3 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3.4 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Speciality Centres, 2021 - 2031 |
6.4.5 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.4 Global Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Peripheral Circulatory Disease Treatment Market, Overview & Analysis |
7.1 North America Peripheral Circulatory Disease Treatment Market Revenues & Volume, 2021 - 2031 |
7.2 North America Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.5 North America Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7 North America Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Peripheral Circulatory Disease Treatment Market, Overview & Analysis |
8.1 Latin America (LATAM) Peripheral Circulatory Disease Treatment Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.5 Latin America (LATAM) Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.7 Latin America (LATAM) Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Peripheral Circulatory Disease Treatment Market, Overview & Analysis |
9.1 Asia Peripheral Circulatory Disease Treatment Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.5 Asia Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.7 Asia Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Peripheral Circulatory Disease Treatment Market, Overview & Analysis |
10.1 Africa Peripheral Circulatory Disease Treatment Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.5 Africa Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.7 Africa Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Peripheral Circulatory Disease Treatment Market, Overview & Analysis |
11.1 Europe Peripheral Circulatory Disease Treatment Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.5 Europe Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.7 Europe Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Peripheral Circulatory Disease Treatment Market, Overview & Analysis |
12.1 Middle East Peripheral Circulatory Disease Treatment Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Peripheral Circulatory Disease Treatment Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.5 Middle East Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.7 Middle East Peripheral Circulatory Disease Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Peripheral Circulatory Disease Treatment Market Key Performance Indicators |
14 Global Peripheral Circulatory Disease Treatment Market - Export/Import By Countries Assessment |
15 Global Peripheral Circulatory Disease Treatment Market - Opportunity Assessment |
15.1 Global Peripheral Circulatory Disease Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Peripheral Circulatory Disease Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Peripheral Circulatory Disease Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.4 Global Peripheral Circulatory Disease Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Peripheral Circulatory Disease Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.6 Global Peripheral Circulatory Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Peripheral Circulatory Disease Treatment Market - Competitive Landscape |
16.1 Global Peripheral Circulatory Disease Treatment Market Revenue Share, By Companies, 2024 |
16.2 Global Peripheral Circulatory Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here